Synlogic
is a Massachusetts-based biopharmaceutical company that researches and develops non-systemically absorbed biotherapeutics to treat genetic disorders... Read moreSynlogic
is a Massachusetts-based biopharmaceutical company that researches and develops non-systemically absorbed biotherapeutics to treat genetic disorders... Read more
News
Nov 13, 2024
Owler
Synlogic, Inc.: Synlogic's revenue changed from $3.17M in Jun 2024 to $2.78M in Sep 2024
Nov 12, 2024
centralcharts
Press Release: Synlogic : Synlogic Reports Third Quarter 2024 Financial Results
May 14, 2024
Owler
Synlogic, Inc.: Synlogic's revenue changed from $3.37M in Dec 2023 to $3.21M in Mar 2024
May 14, 2024
Markets Insider
Synlogic: Synlogic GAAP EPS of -$2.60 misses by $1.80 (NASDAQ:SYBX)
May 14, 2024
MarketScreener
Synlogic: Synlogic : Reports First Quarter 2024 Financial Results - Form 8-K
Apr 22, 2024
Pharamceutical Technology
Synlogic: Synlogic gets grant for genetically engineered bacteria for attenuating metabolic diseases
Mar 28, 2024
Pharamceutical Technology
Synlogic: Synlogic gets grant for genetically engineered bacteria for treating phenylketonuria
Mar 20, 2024
Benzinga
Synlogic: Synlogic, Inc. (SYBX) Reports Q4 Loss, Tops Revenue Estimates
Mar 19, 2024
Marketscreener
Synlogic: Synlogic, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb 20, 2024
centralcharts
Press Release: Synlogic : Synlogic Adopts Limited Duration Stockholders Rights Plan
Synlogic Competitors
1
2
3
4
5
6
7
8
9
10